Interactive Response Technology (IRT) systems automate patient and drug management, reducing errors and increasing efficiency. As the leading IRT specialist in the world, Cenduit has the Randomization and Trial Supply Management (RTSM) expertise to empower clients for success with a tailored solution that puts you in control of your clinical trials.
With the needs of investigator sites and patients top of mind, Cenduit offers clinical supply chain intelligence and clinical operations know-how through its IRT-driven services:
Cenduit was formed in May 2007 as a joint venture between the two leading clinical development and clinical supply chain organizations: Quintiles and Thermo Fisher Scientific. Both parent companies recognized the rapidly increasing demand for patient randomization and drug supply management services, and seized the opportunity through the creation of a specialized IRT (IVR/IWR) solutions provider.
Backed by Quintiles’ unparalleled clinical development experience and using Thermo Fisher Scientific’s unmatched clinical supply chain know-how, Cenduit hit the ground running with a powerful solution that enabled sponsor companies to gain control over this critical portion of the clinical trial process.
Hundreds of trials later, Cenduit has established itself as a best-in-class IRT vendor with a proven track record, and a state-of-the-art IRT platform that enables faster set-up times, easy integration with other systems and seamless IRT delivery.
Cenduit’s Quality First culture, our unrivaled ability to design supply chain processes and our technical expertise in building customized IRT solutions to meet its sponsors’ study-specific requirements continues to position Cenduit as the Go To vendor for IRT services.